David Dellamonica's Email Addresses & Phone Numbers

follow me on @davdellamonica #patient #innovation @Sanofi #Pcsk9 launch unit | #ehealth #epatient #digitalhealth #cvriskscreener #healthdata | Tweets are my own @davdellamonicaHead of Global PCSK9 Patient Advocacy and Innovation @ PCSK9 Development and Launch Unit From May 2014 to Present (1 year 8 months) Paris Area, FranceDirector, Patients Solutions and Innovation - PCSK9 @ From March 2013...

follow me on @davdellamonica #patient #innovation @Sanofi #Pcsk9 launch unit | #ehealth #epatient #digitalhealth #cvriskscreener #healthdata | Tweets are my own @davdellamonicaHead of Global PCSK9 Patient Advocacy and Innovation @ PCSK9 Development and Launch Unit From May 2014 to Present (1 year 8 months) Paris Area, FranceDirector, Patients Solutions and Innovation - PCSK9 @ From March 2013 to Present (2 years 10 months) Paris Area, FranceFounder @ Expanding Patient-Centered Care Strategy To Empower Patients and Assist Providers From June 2012 to Present (3 years 7 months) Co-founder VP @ The French Crohn's and Colitis Foundation “A rope for hope” is a non-profit, volunteer-driven organization dedicated to finding the cure with innovation for Crohn's disease and ulcerative colitis. It was founded in 2008 by Eric Balez, Pr Xavier Hebuterne MD and David Dellamonica. Educational workshops and symposia with the movie “un Mont Blanc pour y croire” (Cannes film selection) and the comics “la cordee du Mont Rose”.... In collaboration with AFA From 2008 to Present (7 years) FranceBoard member @ Eurobiomed is a non-for-profit organisation which has been accredited by the French government as a "healthcare competitive cluster" From June 2012 to 2014 (2 years) Coordination working group > relationship between patients association and pharmacos @ RARE2013 « L'innovation et les partenariats au service des malades » l’atelier A1 : Relations associations de malades et industrie : suivi de l'atelier de RARE 2011 http://www.rare2013.com From June 2013 to December 2013 (7 months) Montpellier Area, FranceCEO Co-founder @ Theralpha is a leading specialty Biopharmaceutical company focused on the development of innovative non-opioide therapies for pain treatment. Mambalgins - THA904 "Black mamba venom peptides target acid-sensing ion channels to abolish pain." Nature advance online publication.Diochot, S., A. Baron, et al. (2012) From August 2009 to March 2013 (3 years 8 months) Strategic Development Director @ TxCell has developed a unique proprietary, breakthrough technology platform, using type 1 regulatory T cells ( TxCell is dedicated to the development of therapeutic products for severe chronic inflammatory and autoimmune diseases with high unmet medical need including inflammatory bowel diseases, inflammatory joint diseases and neurological diseases such as Multiple Sclerosis. The product candidates developed by TxCell consist of antigen-specific Type 1 regulatory cells (Ag-Tregs) generated ex-vivo from patient's peripheral blood in a proprietary manufacturing process. From March 2007 to August 2009 (2 years 6 months) Director and founder of Life Sciences Department @ From October 2003 to March 2007 (3 years 6 months) Nice Area, FranceLife Sicences Business Developpment Manager @ From 2000 to 2003 (3 years) Marketing Manager Virologie, Cardiologie @ From 1998 to 2000 (2 years) Paris Area, FranceMBA @ MBA From 2006 to 2007 Bachelors @ Ecole supérieure de Gestion From 1995 to 1998 The chronic Disease Self-Management Program @ Stanford University School of Medicine David Dellamonica is skilled in: Life Sciences, Clinical, Clinical Development, Commercialization, Treatment, Pharmaceuticals, Technology Transfer, Biotechnology, Forecasting, Product Development, Business Strategy, Biopharmaceuticals, Patents, Licensing, Strategy Development